Trial intelligence / Profile preview

Autologous fibroblast cell therapy for facial skin aging

IRCT201506271159N17Phase 2Completed

Sponsor
Skin and Stem Cell Research Center
Start
Oct 2016
Modality
Cell Therapies
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of M Cell in cutaneous aging and rhytides, sponsored by Skin and Stem Cell Research Center. Started Oct 2016; status: completed.

02

Drugs

M Cell
03

Conditions

cutaneous agingrhytides

Beyond the preview

Go deeper on IRCT201506271159N17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201506271159N17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call